Dr. Julia Stindl
About Dr. Julia Stindl
Dr. Julia Stindl is the Head of Global Post-Market Safety at Novocure, with extensive experience in medical safety and a strong background in medical cell biology and endocrinology.
Title
Dr. Julia Stindl is currently the Head Of Global Post-Market Safety at Novocure.
Current Role at Novocure
Dr. Julia Stindl has been leading the Global Post-Market Safety team at Novocure since July 2020. She is responsible for overseeing post-market surveillance and vigilance, ensuring that safety protocols and compliance are maintained across all regions.
Work Experience at Novocure
Dr. Julia Stindl has held multiple positions at Novocure, accumulating extensive experience in medical safety. She previously served as the Head of Medical Safety EMEA for one year from 2019 to 2020. Before that, she was a Medical Device Safety Specialist for the EMEA region from 2017 to 2019, focusing on compliance and safety protocols. She initially joined Novocure as a Care Coordinator, a role she held for 8 months from 2016 to 2017.
Research Background
Dr. Julia Stindl has a strong research background garnered from various roles at the University of Regensburg. From 2013 to 2016, she worked as a Research Scientist in Medical Cell Biology and Endocrinology. She also conducted research in Cell Physiology, Endocrinology, and Ophthalmology from 2010 to 2012. Early in her career, she gained research experience in Neurobiology and Cell Biology as a Student Research Assistant at University Medical Center Regensburg from 2009 to 2010.
Educational Qualifications
Dr. Julia Stindl completed her education at the University of Regensburg, where she earned multiple degrees. She holds a Doctor of Philosophy (Ph.D.) in Biology, completed from 2011 to 2015. She also obtained a Master of Science (M.Sc.) in Biology from 2008 to 2010, and a Bachelor of Science (B.Sc.) in Biology from 2005 to 2008.